Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
H. Y. Yap(The University of Texas MD Anderson Cancer Center), G. R. Blumenschein, Charles K. Tashima, Philip A. Salem(The University of Texas MD Anderson Cancer Center), G. P. Bodey(The University of Texas MD Anderson Cancer Center), G. N. Hortobagyi(The University of Texas MD Anderson Cancer Center), Aman U. Buzdar(The University of Texas MD Anderson Cancer Center)
PubMed
March 1, 1978
Cited by 61
Related Papers
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
|Journal of Clinical Oncology|2000|996
Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
|Journal of Clinical Oncology|2008|464
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
|The Journal of Infectious Diseases|1985|408
Pseudomonas bacteremia. Retrospective analysis of 410 episodes
|Archives of Internal Medicine|1985|361